From August 1, 2023 to October 31, 2023, the company has repurchased 5,300 shares, representing 0.04% for $0.03 million. With this, the company has completed the repurchase of 120,300 shares, representing 0.89% for $0.71 million under the buyback announced on April 5, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.02 USD | -0.79% | -0.79% | -10.67% |
Mar. 15 | Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023. | CI |
Mar. 13 | Craig-Hallum Downgrades Champions Oncology to Hold From Buy | MT |
1st Jan change | Capi. | |
---|---|---|
-10.67% | 68.24M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- CSBR Stock
- News Champions Oncology, Inc.
- Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.